Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This one page document summarizes costs associated with adopting electronic prescribing of controlled substances in the most widely Continue reading
Resource Tag: Prescription Opioids
Electronic Prescribing of Controlled Substance: Click for Control – An Arizona Campaign to Increase the E-Prescribing of Controlled Substances
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This one page fact sheet explains the new requirement and describes the benefits of electronic prescribing. Continue reading
House Bill 2075: Arizona Revised Statutes Relating to Prescription Orders
This 2019 legislation, signed by Arizona’s governor, requires all health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. Continue reading
PBSS Data Brief: Patient Risk Measures for Controlled Substance Prescriptions in Idaho, 2012-2014
The Prescription Behavior Surveillance System (PBSS) collects deidentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Idaho’s PDMP. Continue reading
PBSS Data Brief: Decline in Patient Prescription Risk Measures in Florida, 2011-2015
The Prescription Behavior Surveillance System (PBSS) collects deidentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Florida’s PDMP. Continue reading
PBSS Data Brief: Patient Risk Measures for Controlled Substance Prescriptions in Delaware, 2012-2015
The Prescription Behavior Surveillance System (PBSS) collects deidentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Delaware’s PDMP. Continue reading
Opioid Use Disorders: Interventions for Community Pharmacists
This 2016 report from The College of Psychiatric and Neurologic Pharmacists provides information for community pharmacists about opioid use disorder and how pharmacists can assist in efforts to reduce prescription misuse and treat opioid use disorder. Continue reading
Pharmacist Toolkit: Benzodiazepine Taper
This 2018 guideline from College of Psychiatric and Neurologic Pharmacists offers advice to pharmacists and providers about tapering patients off long term use of benzodiazepines. Patients prescribed both opioids and benzodiazepines are at higher risk of overdose and death. Continue reading
Opioid Task Force 2019 Progress Report
This 2019 report from the American Medical Association’s Opioid Task Force includes recommendations for physicians and health care providers and policymakers in addressing the opioid epidemic. Continue reading
Public Health Crises and Pharmaceutical Interventions: Improving Access While Ensuring Fiscal Sustainability
This report from the National Governors Association’s Center for Best Practices focuses on strategies states can use to ensure access to pharmaceutical treatments needed to address public health crises. The report addresses opioid related treatment such as medication assisted treatment for opioid use disorder Continue reading